INVASIVE BLADDER-CANCER - (STAGE PT3B, PT4A, PN1, PN2) - REPLY

被引:0
|
作者
STOCKLE, M
机构
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:87 / 88
页数:2
相关论文
共 50 条
  • [41] The Clinical Impact of Extraprostatic Extension and Bladder Neck Invasion in Patients with pT3b Prostate Cancer Undergoing Radical Prostatectomy
    Numbere, Numbereye
    Gurung, Pratik
    Teramoto, Yuki
    Yang, Zhiming
    Miyamoto, Hiroshi
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 947 - 947
  • [42] The Clinical Impact of Extraprostatic Extension and Bladder Neck Invasion in Patients with pT3b Prostate Cancer Undergoing Radical Prostatectomy
    Numbere, Numbereye
    Gurung, Pratik
    Teramoto, Yuki
    Yang, Zhiming
    Miyamoto, Hiroshi
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 947 - 947
  • [43] PDCD4 functions as a suppressor for pT2a and pT2b stage gastric cancer
    Guo, Peng-Tao
    Yang, Dong
    Sun, Zhe
    Xu, Hui-Mian
    ONCOLOGY REPORTS, 2013, 29 (03) : 1007 - 1012
  • [44] Machine learning to predict locoregional relapse in pT1-2pN0-1 breast cancer following mastectomy
    Volpe, S.
    Bellerba, F.
    Zaffaroni, M.
    Pepa, M.
    Isaksson, L. J.
    Maimone, G.
    Menzani, B.
    Monaco, I.
    Maisonneuve, P.
    Scognamiglio, I. R.
    Dicuonzo, S.
    Zerella, M. A.
    Rojas, D. P.
    Marvaso, G.
    Fodor, C.
    Gandini, S.
    De Momi, E.
    Veronesi, P.
    Corso, G.
    Galimberti, V. E.
    Leonardi, M. C.
    Jereczek-Fossa, B. A.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1010 - S1011
  • [45] Does HER-2 status influence locoregionall failure rates after mastectomy in patients with pT1-3pN0 early stage breast cancer?
    Kwan, W.
    Al-Tourah, A. J.
    Speers, C.
    Kennecke, H.
    Norris, B.
    Olivono, I
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S54 - S54
  • [46] The Benefit of Postoperative Radiotherapy and Extending Neck Dissection in pT1-2 Oral Squamous Cell Carcinoma With a Single Ipsilateral Cervical Lymph Node Metastasis (pN1)
    Alsharif, Ubai
    Steller, Daniel
    Falougy, Mohamed
    Tharun, Lars
    Rades, Dirk
    Hakim, Samer G.
    ANTICANCER RESEARCH, 2022, 42 (01) : 97 - 104
  • [47] TRANSURETHRAL RESECTION (TUR) AND NEOADJUVANT CHEMOTHERAPY AS PRIMARY-TREATMENT FOR PT2-PT4, NX, M0 BLADDER-CANCER
    AMIEL, J
    QUINTENS, H
    THYSS, A
    CALDANI, C
    SCHNEIDER, M
    TOUBOL, J
    JOURNAL D UROLOGIE, 1988, 94 (07) : 333 - 336
  • [48] The role of adjuvant chemotherapy after radical surgery in patients with lymph node-positive bladder cancer or locally advanced (pT3, pT4a) bladder cancer: a meta-analysis and systematic review
    Chen, CaiXia
    Wang, ChongJian
    Huang, HaoTian
    Li, HongYuan
    Wen, Zhi
    Liu, Yang
    Yang, Xue-song
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (11) : 7268 - 7280
  • [49] Breast radiotherapy without nodal irradiation in pT1-2 pN0-1 stage: prognostic factors and outcomes.
    Di Carlo, C.
    Nuzzo, M.
    Ursini, L. A.
    Trignani, M.
    Caravatta, L.
    Di Girolamo, G.
    Di Nicola, M.
    Genovesi, D.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S639 - S639
  • [50] Adjuvant therapy for HER2 positive pT1a-b pN0 breast cancer A single center cohort study
    Yang, Xuan
    Qu, Chong Xiao
    MEDICINE, 2022, 101 (25) : E29371